Viewing Study NCT04320693


Ignite Creation Date: 2025-12-25 @ 1:26 AM
Ignite Modification Date: 2025-12-27 @ 4:59 AM
Study NCT ID: NCT04320693
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2021-08-19
First Post: 2020-03-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access for IMMU-132
Sponsor: Gilead Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module